Serum levels of brain-derived neurotrophic factor and thiobarbituric acid reactive substances in chronically medicated schizophrenic patients: A positive correlation

Revista Brasileira de Psiquiatria

Volumn 30, Issue 4, 2008, Pages 337-340

  Gama, Clarissa Severino ^a,b,c   Berk, Michael ^a,c,d,e   Andreazza, Ana Cristina ^a,b   Kapczinski, Flávio ^a,b   Belmonte de Abreu, Paulo ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ORYGEN RESEARCH CENTRE   (Australia)

^e FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Brain derived neurotrophic factor; Nerve growth factors; Schizophrenia; Superoxide dismutase; Thiobarbituric acid reactive substances

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; ONSET AGE; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHRONIC DISEASE; COHORT STUDIES; FEMALE; HUMANS; MALE; NERVE GROWTH FACTORS; SCHIZOPHRENIA; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 58549093744     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-44462008000400006     Document Type: Article

References (16)

1. Gratacos M, Gonzalez JR, Mercader JM, de Cid R, Urretavizcaya M, Estivill X. Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry. 2007;61(7):911-22.
2. Reddy RD, Yao JK. Free radical pathology in schizophrenia: a review. Prostaglandins Leukot Essent Fatty Acids. 1996;55(1-2):33-43.
3. Andreazza AC, Kauer-Sant'anna M, Frey BN, Bond DJ, Kapczinski F, Young LT, Yatham LN. Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord. 2008;111(2-3):135-44.
4. Grignon S, Chianetta JM. Assessment of malondialdehyde levels in schizophrenia: a meta-analysis and some methodological considerations. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(2):365-9.
5. Gama CS, Salvador M, Andreazza AC, Kapczinski F, Silva Belmontede-Abreu P. Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(3):512-5.
6. Gama CS, Salvador M, Andreazza AC, Lobato MI, Berk M, Kapczinski F, Belmonte-de-Abreu PS. Elevated serum thiobarbituric acid reactive substances in clinically symptomatic schizophrenic males. Neurosci Lett. 2008;433(3):270-3.
7. Qian L, Zhao J, Shi Y, Zhao X, Feng G, Xu F, Zhu S, He L. Brain-derived neurotrophic factor and risk of schizophrenia: an association study and meta-analysis. Biochem Biophys Res Commun. 2007;353(3):738-43.
8. Gama CS, Andreazza AC, Kunz M, Berk M, Belmonte-de-Abreu PS, Kapczinski F. Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Neurosci Lett. 2007;420(1):45-8.
9. Salgado JV, Hetem LA, Sandner G. Experimental models of schizophrenia - a review. Rev Bras Psiquiatr. 2006;28(2):135-41.
10. Gabaizadeh R, Staecker H, Liu W, Van De Water TR. BDNF protection of auditory neurons from cisplatin involves changes in intracellular levels of both reactive oxygen species and glutathione. Brain Res Mol Res. 1997;50(1-2):71-8.
11. Radak Z, Toldy A, Szabo Z, Siamilis S, Nyakas C, Silye G, Jakus J, Goto S. The effects of training and detraining on memory, neurotrophins and oxidative stress markers in rat brain. Neurochem Int. 2006;49(4):387-92.
12. Guy W. ECDEU assessment manual for psychopharmacology US Department of Health, Education, and Welfare publication (ADM) 76-338. Rockville, MD: National Institute of Mental Health; 1976. p. 218-22.
13. Azevedo MH, Soares MJ, Coelho I, Dourado A, Valente J, Macedo A, Pato M, Pato C. Using consensus OPCRIT diagnoses. An efficient procedure for best-estimate lifetime diagnoses. Br J Psychiatry. 1999;175:154-7.
14. Mirsa HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem. 1972;217(10):3170-5.
15. Wills ED. Mechanism of lipid peroxide formation in animal tissues. Biochem J. 1966;99(3):667-76.
16. Kapczinski F, Frey BN, Andreazza AC, Kauer- Sant'Anna M, Cunha ABM, Post RM. Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes. Rev Bras Psiquiatr. 2008;30(3):243-5.